Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan.
Muhammad Ishaq GhauriNousheen IqbalSyeda Urooj RiazMuhammad IrfanAjeet KumarMuhamad Shariq MukarramPublished in: BMC research notes (2019)
A prospective study was conducted at Jinnah Medical College Hospital (JMCH) Karachi, Pakistan from July to December 2017. Patients with suspected TbU were started on standard ATT chemotherapy for 12 months. Their response was assessed via slit lamp examination and visual acuity at 1, 3, 6 and 12 months of treatment. Forty patients with probable TbU were treated with ATT, mean age was 36 ± 3 years and 24 (60%) were females. Around 26 (65%) had Monteux test of 15 mm or more. History of TB contact was positive in 24 (60%) and 12 (30%) had previous history of TB. All patients complained for blurring of vision and floaters. Posterior uveitis seen in 36 (90%) of patients. Complete response achieved in 32 (80%) after ATT while 6 (14%) had changed in inflammation and 2 (6%) had no benefit.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- healthcare
- ejection fraction
- prognostic factors
- peritoneal dialysis
- oxidative stress
- mycobacterium tuberculosis
- tertiary care
- ankylosing spondylitis
- radiation therapy
- adverse drug
- locally advanced
- smoking cessation
- acute care
- drug induced
- chemotherapy induced
- replacement therapy